BPG is committed to discovery and dissemination of knowledge
Case Report
©The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Feb 15, 2026; 18(2): 113494
Published online Feb 15, 2026. doi: 10.4251/wjgo.v18.i2.113494
Solitary esophageal metastasis ten years after curative resection of stage I rectal adenocarcinoma: A case report
Yu Zhang, Zi-Xin Li, Dai-Yuan Ma, Fang Liu
Yu Zhang, Zi-Xin Li, Dai-Yuan Ma, Fang Liu, Department of Oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, Sichuan Province, China
Author contributions: Zhang Y and Ma DY designed the research study; Zhang Y and Liu F performed the research; Zhang Y and Li ZX wrote the manuscript; all authors have read and approved the final manuscript.
Informed consent statement: Informed written consent was obtained from the patients for the publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflict of interest to disclose.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Corresponding author: Fang Liu, Department of Oncology, Affiliated Hospital of North Sichuan Medical College, No. 1 Maoyuan South Road, Nanchong 637000, Sichuan Province, China. fang1986121@126.com
Received: August 27, 2025
Revised: November 16, 2025
Accepted: December 25, 2025
Published online: February 15, 2026
Processing time: 160 Days and 16.8 Hours
Abstract
BACKGROUND

We report an exceptionally rare case of a solitary esophageal metastasis occurring in the tenth year after curative resection of stage I (pT2N0M0) rectal adenocarcinoma. This represents one of the longest reported intervals to esophageal metastasis from colorectal cancer, challenging the conventional understanding of metastatic potential of early-stage tumors.

CASE SUMMARY

A 42-year-old male underwent curative resection for rectal adenocarcinoma (pT2N0M0, stage I) in 2015. Ten years later (2025), he presented with progressive dysphagia. Imaging and endoscopy revealed a mid-esophageal tumor with mediastinal lymphadenopathy. Initial biopsy suggested primary esophageal adenocarcinoma. After two cycles of neoadjuvant immunochemotherapy, dysphagia worsened. However, a multidisciplinary team re-evaluation, utilizing comparative immunohistochemistry for the esophageal lesions and rectal specimens, confirmed the diagnosis as a solitary esophageal metastasis from rectal adenocarcinoma (RAS wild-type). The patient received involved-field radiotherapy with concurrent systemic therapy (capecitabine, oxaliplatin and cetuximab). Dysphagia significantly improved one week after radiotherapy initiation. Three-month follow-up imaging after radiotherapy demonstrated a partial response. The patient was on cetuximab maintenance.

CONCLUSION

This case underscores the risk of early tumor recurrence or metastasis beyond standard follow-up windows thus long-term follow-up is necessary.

Keywords: Esophageal metastasis; Colorectal cancer; Recurrence; Tumor dormancy; Radiotherapy; Case report

Core Tip: We report a case of a solitary esophageal metastasis occurring in the tenth year after curative resection of stage I rectal adenocarcinoma, representing one of the longest intervals for rectal metastasis to the esophagus. It emphasizes that even early-stage tumors can metastasize to atypical sites after years. Furthermore, we discuss the role of immunohistochemistry in diagnosis and the potential value of radiotherapy combined with systemic treatment.

Write to the Help Desk